![Andriy Mushak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andriy Mushak
Financieel Directeur/CFO bij
TELOMIR PHARMACEUTICALS, INC.
Profiel
Andriy Mushak began working as Chief Financial Officer at Telomir Pharmaceuticals, Inc. in 2026 and continues in this role.
In the same year, Mr. Mushak also started as Chief Financial Officer at MIRA Pharmaceuticals, Inc. and remains in this position.
Actieve functies van Andriy Mushak
| Bedrijven | Functie | Begin |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 06-06-2026 |
| MIRA PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 06-06-2026 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
1
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
Kies MarketScreener 
